期刊文献+

Galectin-3-centered paracrine network mediates cardiac inflammation and fibrosis upon β-adrenergic insult 被引量:5

原文传递
导出
摘要 Rapid over-activation of β-adrenergic receptors (β-AR) following acute stress initiates cardiac inflammation and injury by activating interleukin-18 (IL-18),however,the process of inflammation cascades has not been fully illustrated.The present study aimed to determine the mechanisms of cardiac inflammatory amplification following acute sympathetic activation.With bioinformatics analysis,galectin-3 was identified as a potential key downstream effector of β-AR and IL-18 activation.The serum level of galectin-3 was positively correlated with norepinephrine or IL-18 in patients with chest pain.In the heart of mice treated with β-AR agonist isoproterenol (ISO,5 mg kg^(-1)),galectin-3 expression was upregulated markedly later than IL-18 activation,and Nlrp3^(-/-)and Il18^(-/-)mice did not show ISO-induced galectin-3 upregulation.It was further revealed that cardiomyocyte-derived IL-18 induced galectin-3 expression in macrophages following ISO treatment.Moreover,galectin-3deficiency suppressed ISO-induced cardiac inflammation and fibrosis without blocking ISO-induced IL-18 increase.Treatment with a galectin-3 inhibitor,but not a β-blocker,one day after ISO treatment effectively attenuated cardiac inflammation and injury.In conclusion,galectin-3 is upregulated to exaggerate cardiac inflammation and injury following acute β-AR activation,a galectin-3 inhibitor effectively blocks cardiac injury one day after β-AR insult.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2023年第5期1067-1078,共12页 中国科学(生命科学英文版)
基金 supported by the National Key R&D Program of China (2021YFF0501401) the National Natural Science Foundation of China (82030072) the Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research (BMU2019JI007) the Fundamental Research Funds for the Central Universities the National Natural Science Foundation of China (81830009, 81822003) the Beijing Municipal Natural Science Foundation (7191013) the Key Clinical Projects of Peking University Third Hospital (BYSYZD2019022) CAMS Innovation Fund for Medical Sciences to (2021-I2M-5-003)。
  • 相关文献

同被引文献18

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部